| scholarly article | Q13442814 |
| P50 | author | Curt D. Sigmund | Q40187956 |
| Travice De Silva | Q64623399 | ||
| Frank M Faraci | Q86046795 | ||
| P2093 | author name string | Chunyan Hu | |
| Mary L Modrick | |||
| Dale A Kinzenbaw | |||
| P2860 | cites work | Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension | Q22011018 |
| Cerebral Small Vessel Disease: Targeting Oxidative Stress as a Novel Therapeutic Strategy? | Q26751153 | ||
| Recent insights into the cellular biology of atherosclerosis | Q30300194 | ||
| The neurovascular dysfunction induced by angiotensin II in the mouse neocortex is sexually dimorphic | Q33304970 | ||
| Sex differences in acute ANG II-mediated hemodynamic responses in mice | Q34150265 | ||
| Role of peroxisome proliferator-activated receptor-γ in vascular muscle in the cerebral circulation | Q34315697 | ||
| Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis | Q34604937 | ||
| Diabetes and atherosclerosis: epidemiology, pathophysiology, and management | Q34646074 | ||
| Genetic interference with peroxisome proliferator-activated receptor γ in smooth muscle enhances myogenic tone in the cerebrovasculature via A Rho kinase-dependent mechanism | Q34892807 | ||
| Protecting against vascular disease in brain | Q34979773 | ||
| Emerging translational approaches to target STAT3 signalling and its impact on vascular disease | Q35580177 | ||
| International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. | Q36241932 | ||
| Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARγ and RhoA/Rho-kinase. | Q36328405 | ||
| Targeting Rho and Rho-kinase in the treatment of cardiovascular disease | Q36352966 | ||
| Interference with PPAR gamma function in smooth muscle causes vascular dysfunction and hypertension. | Q36509300 | ||
| Interference with PPARγ in endothelium accelerates angiotensin II-induced endothelial dysfunction | Q36510633 | ||
| Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertension | Q36660171 | ||
| Interference with PPARgamma signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling. | Q36692337 | ||
| Endothelial PPAR-γ provides vascular protection from IL-1β-induced oxidative stress | Q36699263 | ||
| Role of chemokine RANTES in the regulation of perivascular inflammation, T-cell accumulation, and vascular dysfunction in hypertension. | Q36812077 | ||
| Dominant negative PPARγ promotes atherosclerosis, vascular dysfunction, and hypertension through distinct effects in endothelium and vascular muscle | Q36837948 | ||
| Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet. | Q36972995 | ||
| Context-dependent effects of SOCS3 in angiotensin II-induced vascular dysfunction and hypertension in mice: mechanisms and role of bone marrow-derived cells | Q37139653 | ||
| Carotid intimal medial thickness predicts cognitive decline among adults without clinical vascular disease | Q37366566 | ||
| Cullin-3 mutation causes arterial stiffness and hypertension through a vascular smooth muscle mechanism | Q37417507 | ||
| Does peroxisome proliferator-activated receptor-gamma (PPAR gamma) protect from hypertension directly through effects in the vasculature? | Q37686890 | ||
| Angiotensin-(1-7). | Q38198985 | ||
| Endothelial NADPH oxidases: which NOX to target in vascular disease? | Q38234422 | ||
| Heterogeneous Impact of ROCK2 on Carotid and Cerebrovascular Function | Q39586548 | ||
| NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox | Q40331102 | ||
| Using the mouse to model human disease: increasing validity and reproducibility | Q42599011 | ||
| Peroxisome proliferator-activated receptor-γ mutations responsible for lipodystrophy with severe hypertension activate the cellular renin-angiotensin system | Q44434235 | ||
| Critical role for CuZn-superoxide dismutase in preventing angiotensin II-induced endothelial dysfunction | Q46745889 | ||
| IL-6 deficiency protects against angiotensin II induced endothelial dysfunction and hypertrophy | Q46930205 | ||
| Gender affects renal vasoconstrictor response to Ang I and Ang II. | Q50910668 | ||
| Characterization of a new selective antagonist for angiotensin-(1-7), D-pro7-angiotensin-(1-7). | Q51839155 | ||
| Genetic Variation in PPARG Encoding Peroxisome Proliferator-Activated Receptor γ Associated With Carotid Atherosclerosis | Q58771200 | ||
| Longitudinal studies of estrous cyclicity in aging C57BL/6J mice: II. Cessation of cyclicity and the duration of persistent vaginal cornification | Q70798129 | ||
| Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries | Q73762643 | ||
| Angiotensin-(1-7) causes endothelium-dependent relaxation in canine middle cerebral artery | Q74071611 | ||
| Angiotensin-(1-7) modulates angiotensin II-induced vasoconstriction in human mammary artery | Q85737219 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 559-565 | |
| P577 | publication date | 2017-07-03 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Genetic Interference With Endothelial PPAR-γ (Peroxisome Proliferator-Activated Receptor-γ) Augments Effects of Angiotensin II While Impairing Responses to Angiotensin 1-7 | |
| P478 | volume | 70 |
| Q90747615 | Contributions of Aging to Cerebral Small Vessel Disease |
| Q54979587 | Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Is Essential for Preventing Endothelial Dysfunction With Aging. |
| Q57787242 | Interference With Endothelial PPAR (Peroxisome Proliferator-Activated Receptor)-γ Causes Accelerated Cerebral Vascular Dysfunction in Response to Endogenous Renin-Angiotensin System Activation |
| Q47793724 | PPARγ and retinol binding protein 7 form a regulatory hub promoting antioxidant properties of the endothelium. |
| Q92928281 | The Nuclear Export and Ubiquitin-Proteasome-Dependent Degradation of PPARγ Induced By Angiotensin II |
Search more.